Bright Minds Biosciences Inc. (DRUG)

NASDAQ: DRUG · Real-Time Price · USD

70.71

+4.55 (6.88%)

Nov 28, 2025, 4:00 PM EST - Market closed

Bright Minds Biosciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2019
Period Ending	Nov '25 Nov 28, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	2019
Market Capitalization	509	5	6	20	85	-	Upgrade
Market Cap Growth	7034.52%	-18.98%	-70.74%	-75.79%	-	-	Upgrade
Enterprise Value	472	0	0	14	67	-	Upgrade
Last Close Price	70.00	1.17	1.60	6.15	35.71	-	Upgrade
PB Ratio	13.38	1.19	1.23	2.67	5.51	-	Upgrade
P/TBV Ratio	13.38	1.19	1.23	2.67	5.52	-	Upgrade
Debt / Equity Ratio	0.00	0.02	0.01	0.01	-	-	Upgrade
Quick Ratio	85.39	10.92	24.16	8.00	31.12	5.30	Upgrade
Current Ratio	86.56	11.32	24.26	8.11	31.38	5.82	Upgrade
Return on Equity (ROE)	-30.79%	-46.18%	-86.02%	-99.95%	-85.94%	-124.04%	Upgrade
Return on Assets (ROA)	-18.31%	-25.19%	-47.45%	-57.32%	-51.52%	-61.70%	Upgrade
Return on Capital (ROIC)	-18.53%	-26.53%	-51.86%	-61.21%	-53.54%	-76.64%	Upgrade
Return on Capital Employed (ROCE)	-16.60%	-46.90%	-109.10%	-138.80%	-44.40%	-65.10%	Upgrade
Earnings Yield	-1.29%	-42.70%	-90.90%	-53.20%	-8.09%	-	Upgrade
Buyback Yield / Dilution	-49.67%	-15.87%	-50.58%	-37.64%	-148.42%	-74.24%	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q